Market Cap ₹25 Cr.
Stock P/E
P/B 1.7
Current Price ₹61
Book Value ₹ 35.5
Face Value 10
52W High ₹97
Dividend Yield 0%
52W Low ₹ 50.8
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|
Net Sales | 20 | 46 | 85 | 70 | |
Other Income | 0 | 0 | 0 | 0 | |
Total Income | 20 | 46 | 85 | 70 | |
Total Expenditure | 19 | 44 | 81 | 67 | |
Operating Profit | 1 | 3 | 4 | 3 | |
Interest | 0 | 0 | 0 | 0 | |
Depreciation | 0 | 0 | 1 | 0 | |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | |
Profit Before Tax | 0 | 2 | 3 | 3 | |
Provision for Tax | 0 | 0 | 1 | 1 | |
Profit After Tax | 0 | 1 | 2 | 2 | |
Adjustments | 0 | 0 | 0 | 0 | |
Profit After Adjustments | 0 | 1 | 2 | 2 | |
Adjusted Earnings Per Share | 1.1 | 4.1 | 7.1 | 11.8 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | -18% | 52% | 0% | 0% |
Operating Profit CAGR | -25% | 44% | 0% | 0% |
PAT CAGR | 0% | 0% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | -24% | NA% | NA% | NA% |
ROE Average | 23% | 39% | 33% | 33% |
ROCE Average | 27% | 35% | 30% | 30% |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Shareholder's Funds | 2 | 3 | 5 | 12 |
Minority's Interest | 0 | 0 | 0 | 0 |
Borrowings | 3 | 3 | 2 | 0 |
Other Non-Current Liabilities | -0 | -0 | -0 | -0 |
Total Current Liabilities | 1 | 4 | 3 | 6 |
Total Liabilities | 6 | 10 | 11 | 18 |
Fixed Assets | 1 | 1 | 1 | 1 |
Other Non-Current Assets | 0 | 0 | 0 | 0 |
Total Current Assets | 5 | 9 | 9 | 17 |
Total Assets | 6 | 10 | 11 | 18 |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 0 | 0 | 1 |
Cash Flow from Operating Activities | 0 | 0 | 0 | -3 |
Cash Flow from Investing Activities | 0 | 0 | 0 | -0 |
Cash Flow from Financing Activities | 0 | 0 | 0 | 3 |
Net Cash Inflow / Outflow | 0 | 0 | 0 | 0 |
Closing Cash & Cash Equivalent | 0 | 0 | 0 | 1 |
# | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Earnings Per Share (Rs) | 1.06 | 4.14 | 7.06 | 11.81 |
CEPS(Rs) | 1.81 | 5.8 | 8.93 | 14.28 |
DPS(Rs) | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 7.89 | 10.49 | 17.47 | 71.88 |
Core EBITDA Margin(%) | 4.55 | 5.42 | 4.24 | 4.26 |
EBIT Margin(%) | 3.47 | 4.34 | 3.61 | 3.85 |
Pre Tax Margin(%) | 2.1 | 3.58 | 3.32 | 3.8 |
PAT Margin (%) | 1.57 | 2.69 | 2.49 | 2.85 |
Cash Profit Margin (%) | 2.66 | 3.76 | 3.15 | 3.45 |
ROA(%) | 5.01 | 15.06 | 20.5 | 13.86 |
ROE(%) | 13.49 | 45.04 | 50.48 | 22.92 |
ROCE(%) | 14.47 | 35.31 | 43.82 | 27.08 |
Receivable days | 57.56 | 36.92 | 27.21 | 37.15 |
Inventory Days | 0 | 0 | 0 | 0 |
Payable days | 0 | 0 | 0 | 0 |
PER(x) | 0 | 0 | 0 | 6.09 |
Price/Book(x) | 0 | 0 | 0 | 1 |
Dividend Yield(%) | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0.14 | 0.07 | 0.02 | 0.16 |
EV/Core EBITDA(x) | 3.1 | 1.35 | 0.54 | 3.62 |
Net Sales Growth(%) | 0 | 126.75 | 83.83 | -18.08 |
EBIT Growth(%) | 0 | 183.74 | 52.92 | -12.67 |
PAT Growth(%) | 0 | 288.91 | 70.48 | -6.25 |
EPS Growth(%) | 0 | 288.91 | 70.48 | 67.41 |
Debt/Equity(x) | 1.07 | 1.06 | 0.44 | 0.02 |
Current Ratio(x) | 3.28 | 2.36 | 2.98 | 2.86 |
Quick Ratio(x) | 3.28 | 2.36 | 2.98 | 2.86 |
Interest Cover(x) | 2.53 | 5.68 | 12.27 | 80.06 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0.01 |
# | Mar 2023 | Sep 2023 | Mar 2024 |
---|---|---|---|
Promoter | 73.53 | 73.53 | 73.53 |
FII | 0 | 0 | 0 |
DII | 0 | 0 | 0 |
Public | 26.47 | 26.47 | 26.47 |
Others | 0 | 0 | 0 |
Total | 100 | 100 | 100 |
# | Mar 2023 | Sep 2023 | Mar 2024 |
---|---|---|---|
Promoter | 0.3 | 0.3 | 0.3 |
FII | 0 | 0 | 0 |
DII | 0 | 0 | 0 |
Public | 0.11 | 0.11 | 0.11 |
Others | 0 | 0 | 0 |
Total | 0.41 | 0.41 | 0.41 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About